The Cochrane collaboration has stated over and over: the flu vaccine does not bring any benefit.
In other words, there is no point to get it.
And we know that the number of deaths caused by the flu is way exaggerated.
The CDC’s website traditionally has stated that about thirty-six thousand Americans die from the flu each year. This figure is commonly accepted and widely reported by the media and the scientific community.
For the 2018-2019 U.S. flu season (October 1, 2018, through May 4, 2019), the CDC reported between 37.4 million and 42.9 million flu illnesses, from 17.1 million to 20.1 million medical visits; between 531,000 and 647,000 hospitalizations; and between 36,400 and 61,200 deaths.
A physician who submitted a “request for correction” to the U.S. Department of Health and Human Services (HHS) has written that the data on influenza deaths are “false and misleading.”
The writer notes that although the CDC acknowledges a difference between “flu” deaths and “flu-associated” deaths, it uses the terms interchangeably and avoids telling us that the much-publicized figure of thirty-six thousand is not actually an estimate of yearly flu deaths “but an estimate (generated by a mathematical model) of flu-associated death.”
You can read his full letter here:
Fraudulently, the CDC is bundling flu and pneumonia deaths together, thus grossly inflating the numbers. The physician also points to “significant statistical incompatibilities between official estimates and national vital statistics data.”
According to the National Center for Health Statistics, deaths for which the cause is listed as influenza on death certificates number little more than one thousand per year.
You read it right: only a thousand is directly associated with the flu. The other 35 000 deaths are associated with pneumonia and cold-related illnesses.
Before getting a flu shot, you should know that influenza vaccine injury and death claims are the leading types of claims submitted to the National Vaccine Injury Compensation Program (NVICP), and the second most frequently compensated.
Congress established the NVICP in 1986 to give families of vaccinated children an avenue for vaccine injury compensation while absolving drug companies from liability for injuries and deaths. To date, the NVICP has compensated a total of six thousand three hundred and fifty-eight claims, paying victims over four billion dollars—and two-thirds of the claims involved flu vaccines.
You can read more about this here:
In addition, we have strong evidence that the flu vaccine is harmful during pregnancy and that it can lead to miscarriage.
Package inserts of the A-H1N1 vaccine caution: “It is not known whether these vaccines can cause fetal harm when administered to pregnant women or can affect reproduction capacity.”22 However, numerous studies show that influenza vaccines are, in fact, harming pregnant women and their fetuses.
For example, the CDC’s own data demonstrated that women who received certain flu shots from 2010 to 2012 had 7.7-fold greater odds of miscarriage than women who did not receive the vaccines.
A 2017 Kaiser study of over forty-five thousand women, published in JAMA Pediatrics, showed an elevated risk of birth defects and a 20 percent higher risk of autism in children whose mothers received a first-trimester flu shot.
However, other evidence from the CDC indicates that pregnant women who receive flu vaccines are four times more likely to be hospitalized for influenza-like illness than unvaccinated pregnant women.
Children who receive trivalent inactivated influenza vaccines are three times more likely to be hospitalized for influenza-related complications than children who do not get the vaccine.
Studies also show that children who receive influenza vaccines are more likely than non-vaccinated children to develop respiratory infections; specifically, influenza-vaccinated children have a significantly increased risk of developing acute non-influenza respiratory illnesses from rhinoviruses, coxsackieviruses, and echoviruses.
A little-disclosed fact is that influenza vaccines are responsible for spreading the disease to other people through a process called shedding. According to the CDC’s website, both children and adults vaccinated with live-attenuated influenza vaccine (LAIV) “can shed vaccine viruses after receipt of LAIV,” although the CDC also asserts that post-vaccine shedding occurs less than it does the following infection with wild-type influenza viruses.
It is interesting to me that those vaccine pushers claim that shedding is not a thing, but the CDC says it is… Who is right? 😊
A study published in the Journal of American Physicians and Surgeons, which analyzed eighteen years of data, found that people who received live-virus influenza vaccines could transmit the disease to people they came in contact with, including pregnant women and those with weak immunity.29 Even more troublesome, these researchers hypothesized that live-virus influenza vaccines could potentially cause a “super virus” if the vaccine strain were to recombine with another viral infection contracted by the vaccinated person.
Due to public outcry, manufacturers reportedly removed thimerosal from childhood vaccines as a “precautionary measure” in 2001. Today, however, all multiuse vials of influenza vaccine still contain the mercury-based preservative. Moreover, ethylmercury is fifty times more toxic than the methylmercury found in fish and twice as persistent in the brain.
The state of California recognizes thimerosal as a reproductive toxicant that has been found to cause severe mental retardation or malformations in the offspring of mothers who were exposed to the neurotoxicant while pregnant.
Individuals over age sixty-five account for more than nine in ten influenza-related deaths. In the 1980s and 1990s, notwithstanding a fourfold increase in the percentage of seniors who received influenza vaccines, CDC epidemiologists found that national influenza-related death rates actually increased.
Today, because seniors appear to have low immune responses to influenza vaccines, the CDC recommends that the sixty-five-plus age group receive the Fluzone High-Dose influenza vaccine, which contains four times the amount of flu virus antigen as the vaccine previously used for seniors. The FDA approved the Fluzone High-Dose vaccine in December 2009, even though the CDC’s Advisory Committee on Immunization Practices (ACIP) made no indication that it was better than the prior Fluzone formulation.
Between 2013 and 2017—when High-Dose Fluzone was widely administered—the flu death rate among Americans over sixty-five years of age jumped 328.6 percent.
Another falsehood perpetuated by the CDC about flu vaccination is that it reduces all-cause winter mortality for seniors by about 50 percent. This is an astonishing claim, given that only about 5 percent of all winter deaths are attributable to influenza. Some CDC researchers admit that extensive selection bias may explain the astounding overestimation of influenza vaccine effectiveness in the elderly.
According to a revealing BMJ review, officials’ justification of influenza vaccine policies often relies on low-quality studies that fail to substantiate claims of safety and effectiveness.
Australia suspended flu shots in children under age five after discovering that one in every one hundred and ten influenza-vaccinated children were experiencing febrile convulsions; H1N1 influenza vaccination in Finland and Sweden was associated with a spike in narcolepsy among adolescents (about one in fifty-five thousand vaccinated teens).
A study in Lancet Infectious Diseases revealed that annual vaccination of young children against common influenza strains could be counterproductive, preventing them from acquiring more comprehensive immunity and leaving them unprotected against pandemic strains.
In contrast, people who are naturally exposed to circulating influenza viruses (meaning unvaccinated individuals) are more likely to gain cross-protection against other strains.
Analysts expect the global vaccine market to draw total revenues of 59.2 billion U.S. dollars by 202 0. The global influenza vaccine market is expected to grow at a compound growth rate of 6.37% to reach 7.5 billion dollars by 2024, up from 5.2 billion dollars in 2018.
Do not get me wrong, it is not about the money! 😊
God bless y’all 😊